Navigation Links
Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
Date:12/7/2007

pment efforts will succeed, or whether other developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
2. Medarex to Present at the JPMorgan Small/Mid Cap Conference
3. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. DaVita Receives Civil Complaint
7. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
8. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
9. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
10. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...s a critical role in the development of the kidney...nstantly available to produce the differentiated c...gan, //according to investigators at St. Jude Chil...process by which a progenitor (unspecialized) cell...
...nducted by S. Kankova and colleagues from the Depa... Charles University; the Centre of Reproductive Me...en with dormant toxoplasmosis are more likely to d...a negative. // Toxoplasma gondii is one of the mo...
...tific evidence that moderate consumption of beer o...rnment as one to two servings daily -- may actuall...at all.// Research conducted on the potential heal...c beverages will be presented in the nation’s capi...
...cans develop pneumococcal pneumonia -- a common ba...ly fatal, illness. The October issue of Mayo Clini...ccine is available that helps protect //against th...duces the serious complications of the disease. M...
Other Medicine News:Health News:Key Gene Controlling Kidney Development Found 2Health News:Effect of parasitic infection on baby's sex 2Health News:Science Behind Health Benefits of Moderate Beer Consumption 2Health News:Science Behind Health Benefits of Moderate Beer Consumption 3
(Date:10/6/2008)...r 7 /-,Sosei Group Corporat...,Group plc ("Vectura"; LSE: VEC), announce results...safety and tolerability of NVA237 presented at the...ty (ERS) in Berlin,Germany. The new data show tha... long-acting muscarinic antagonist (LAMA), provide...
(Date:10/6/2008)...e understanding of and possible treatment...RICA, Mass., Oct. 6 /- Seahorse Biosc...r analytical instrument for the,kinetic measuremen...mic,glycolysis in cells in a 96 well microplate. F...bioenergetics have been relatively unchanged since...
(Date:10/6/2008)...he American College of Nutrition ...Newswire/ -- New research on the benefits of,probi... American College of,Nutrition (ACN) Annual Meetin...otics in Health and Disease." Scientific experts i...iscussed the potential uses for,probiotics in chil...
(Date:10/6/2008)...t. 6 /- Complete,Genomics Inc., a new...ing,company, and the Institute for Systems Biology...t populationwide human genome studies., In phase ... proprietary,DNA sequencing technology to sequence...once proof-of-concept has been demonstrated, ISB a...
Breaking Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2BRCA1 Mutation Prevalent Among Hispanic Younger Black Women 8790 1BRCA1 Mutation Prevalent Among Hispanic Younger Black Women 8790 2BRCA1 Mutation Prevalent Among Hispanic Younger Black Women 8790 3Photo monitoring whale sharks 1728 1Photo monitoring whale sharks 1728 2Why fish oil is good for you 8785 1Why fish oil is good for you 8785 2Why fish oil is good for you 8785 3Anthracyclines improve survival in HER2 positive breast cancer patients 8782 1Anthracyclines improve survival in HER2 positive breast cancer patients 8782 2
...ing: The Procleix System has added a significant ... utilizes innovative technologies developed by Gen...eic acid amplification technique called Transcript...V-1/HCV Assay can simultaneously detect the presen...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca
...assay: Uni-Gold Recombigen HIV is a single use rap...in plasma, serum and whole blood (venipuncture). U...t of care settings as an aid in diagnosis of infec...appropriate multi-test algorithms designed for the...
The advanced performance benefits of TiMAX material have been applied to the ACE Pe.R.I. (Periarticular Reduction Implants) Upper Extremity Plates. Greater strength, less rigidity combine to provide
Medicine Products: